Biopharmaceutical classification of poorly soluble drugs with respect to “enabling formulations”Stephen T. Buckley, Martin Brandl, Kerstin J. Frank et al.|European Journal of Pharmaceutical Sciences|2013Cited by 209
In vitro models to evaluate the permeability of poorly soluble drug entities: Challenges and perspectivesStephen T. Buckley, Martin Brandl, Gert Fricker et al.|European Journal of Pharmaceutical Sciences|2011Cited by 145
Amorphous solid dispersion enhances permeation of poorly soluble ABT-102: True supersaturation vs. apparent solubility enhancementKerstin J. Frank, Martin Brandl, Karin M. Rosenblatt et al.|International Journal of Pharmaceutics|2012Cited by 141